“We welcome the successful interim results of the Pfizer and Biotech vaccines published today.
We firmly believe that the world needs a large portfolio of successful vaccines across multiple platforms.
We also intend to publish interim data on the effectiveness of clinical trials "Sputnik V" in November, "- said in a statement Dmitriev.
Earlier, the American corporation Pfizer and the bioengineering company BioNTech announced a successful third phase of clinical trials of the vaccine they developed against COVID-19.
The US vaccine registration is expected to take place in November.